Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

ClinicalTrials.gov ID: NCT00934375

Public ClinicalTrials.gov record NCT00934375. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 11:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multi-center, open-label study of 28 weeks duration in subjects with Mild Cognitive Impairment who have completed the double-blind study (E2020-A001-412).

Study identification

NCT ID
NCT00934375
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Eisai Inc.
Industry
Enrollment
145 participants

Conditions and interventions

Eligibility (public fields only)

Age range
45 Years to 90 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2006 (Type not available)
Primary completion
Sep 2007 (Actual)
Completion
Sep 2007 (Actual)
Last update posted
Jan 14, 2014

2006 – 2007

United States locations

U.S. sites
49
U.S. states
17
U.S. cities
46
Facility City State ZIP Site status
Neurology Neurodiagnostic Lab, LLC Alabaster Alabama 35007 —
Pivotal Research Centers Peoria Arizona 85381 —
Sun Health Research Institute Sun City Arizona 85351 —
Northwest Neurospecialists, PLLC Tucson Arizona 85741-3537 —
The Neurology Center Encinitas California 92024 —
Margolin Brain Institute Fresno California 93720 —
Colaborative Neuroscience Network (CNS Network) Garden Grove California 92845 —
Nerve Pro Research Irvine California 92618 —
Optimum Health Services La Mesa California 91942 —
Pacific Research Network San Diego California 92103 —
Neurological Research Institute Santa Monica California 90404 —
CA Neuroscience Research Sherman Oaks California 91403 —
Pacific Research Network Vista California 92081 —
Yale University Alzheimers Disease Research Unit School of Medicine Department of Psychiatry New Haven Connecticut 06510 —
North Broward Medical Center Memory Disorder Center Deerfield Beach Florida 33064 —
Neurologic Consultants Fort Lauderdale Florida 33308 —
Berma Research Group Hialeah Florida 33016 —
Sunrise Clinical Research Hollywood Florida 33021 —
Wien Center for Memory Disorders, Mount Sinai Medical Center Miami Beach Florida 33140 —
Berma Research Group Plantation Florida 33317 —
The Roskamp Institute Sarasota Florida 34243 —
Comprehensive Neuroscience, Inc. St. Petersburg Florida 33702 —
Stedman Clinical Trials, LLC Tampa Florida 33613 —
USF Memory Disorder's Clinic Tampa Florida 33613 —
USF Suncoast Gerontalogy Center Tampa Florida 33617 —
Center for Clinical Trials. L.C. Venice Florida 34285 —
Palm Beach Neurology West Palm Beach Florida 33407 —
Lexington Clinic Lexington Kentucky 40504 —
Borgess Research Institute Kalamazoo Michigan 49048 —
St. Louis University - Clinical Trials Unit St Louis Missouri 63104 —
Comprehensive Neuroscience, Inc Kenilworth New Jersey 07033 —
Neurological Associates of Albany, PC Neurology Albany New York 12208 —
Neurobehavioral Research Inc. Lawrence New York 11559 —
New York University School of Medicine Aging and Dementia Research Center New York New York 10016 —
Columbia University New York New York 10032 —
Monroe Community Hospital Program in Neurobehavioral Therapeutics Rochester New York 14620 —
Behavioral Medical Research of Staten Island Staten Island New York 10305 —
The Ohio State University Columbus Ohio 43210 —
Neurology Center of Ohio Toledo Ohio 43623 —
Pahl Pharmaceutical Research, LLC Oklahoma City Oklahoma 73118 —
Summit Research Network(Oregon) Inc. Portland Oregon 97210 —
Clinical Trial Specialists Bala-Cynwyd Pennsylvania 19004 —
Westmoreland Neurology Associates Greensburg Pennsylvania 15601 —
The Clinical Trial Center, LLC Jenkintown Pennsylvania 19046 —
Medical University of South Carolina-Alzheimer's Research Charleston South Carolina 29406 —
The University of Texas Mental Sciences Instittute Houston Texas 77030 —
START Center San Antonio Texas 78229-3900 —
Grayline Clinical Drug Trials Wichita Falls Texas 76309 —
Southwestern Vermont Medical Center - The Memory Clinc Bennington Vermont 05201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00934375, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 14, 2014 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00934375 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →